MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M

Stock Information for C21 Investments Inc - Ordinary Shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About C21 Investments Inc - Ordinary Shares

MediPharm Labs Announces Strong Q1 2025 Results
MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders
MediPharm Labs Sets Date to Report First Quarter 2025 Financial Results
MediPharm Labs Responds to Dissident Shareholder's Filing
Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction
MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial Results
MediPharm Labs Announces Termination of the Proposed Sale of Napanee Facility to Kensana Health

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.